Cargando…
Impact of sodium glucose linked cotransporter‐2 inhibition on renal microvascular oxygen tension in a rodent model of diabetes mellitus
BACKGROUND: The mechanisms whereby inhibitors of sodium‐glucose linked cotransporter‐2 (SGLT2) exert their nephroprotective effects in patients with diabetes are incompletely understood but have been hypothesized to include improved tissue oxygen tension within the renal cortex. The impact of SGLT2...
Autores principales: | Hare, Gregory M. T., Zhang, Yanling, Chin, Kyle, Thai, Kerri, Jacobs, Evelyn, Cazorla‐Bak, Melina P., Nghiem, Linda, Wilson, David F., Vinogradov, Sergei A., Connelly, Kim A., Mazer, C. David, Evans, Roger G., Gilbert, Richard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239445/ https://www.ncbi.nlm.nih.gov/pubmed/34184431 http://dx.doi.org/10.14814/phy2.14890 |
Ejemplares similares
-
Dual inhibition of sodium–glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction
por: Connelly, Kim A., et al.
Publicado: (2018) -
Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease
por: Zhang, Yanling, et al.
Publicado: (2016) -
Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
por: Connelly, Kim A., et al.
Publicado: (2019) -
Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD
por: Kepecs, David M, et al.
Publicado: (2016) -
Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trial
por: Yuen, Darren A., et al.
Publicado: (2015)